Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Pharmaceuticals 16.4 (2023): 598.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2023
- Urheber
-
Yin, Jie
Zhao, Gangyin
Kalirai, Helen
Coupland, Sarah E.
Jochemsen, Aart G.
Forn-Cuní, Gabriel
Wierenga, Annemijn P. A.
Jager, Martine J.
Snaar-Jagalska, B. Ewa
Groenewoud, Arwin
- DOI
-
10.3390/ph16040598
- URN
-
urn:nbn:de:bvb:29-opus4-228580
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yin, Jie
- Zhao, Gangyin
- Kalirai, Helen
- Coupland, Sarah E.
- Jochemsen, Aart G.
- Forn-Cuní, Gabriel
- Wierenga, Annemijn P. A.
- Jager, Martine J.
- Snaar-Jagalska, B. Ewa
- Groenewoud, Arwin
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2023
Ähnliche Objekte (12)
Molecular and preclinical evaluation of patient-derived orthotopic xenograft models of pediatric brain tumors
ITCC-P4: Molecular characterization and multi-omics analysis of pediatric patient tumor and Patient-Derived Xenograft (PDX) models for preclinical model selection
PFKFB3-Inhibition während einer Radiochemotherapie des Rektumkarzinoms – Überprüfung in einem patient-derived xenograft In-vivo-Modell
Colorectal cancer patient-derived xenograft (PDX) models as platform for drug screening, molecular and response analysis
Characterization of dormant and drug resistant stem cells using xenograft mouse models of patient-derived acute leukemia cells
Improving organotypic non-melanoma skin cancer models for advanced preclinical drug evaluation
Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy
Evaluation of photon, proton, helium, and carbon ion irradiation in prototypic NSCLC and HNSCC preclinical xenograft models
Hyperacute xenograft rejection
Impact of the injection site on growth characteristics, phenotype and sensitivity towards cytarabine of twenty acute leukaemia patient-derived xenograft models
A larval zebrafish xenograft model: evaluation of leukemia-niche interactions and its potential to predict relapsing leukemia
Enhancing Precision Oncology : Preclinical Assessment of Individual Drug Treatment Susceptibility Using Patient-Derived 3D Microtumor and Immune Cell Co-cultures
Molecular and preclinical evaluation of patient-derived orthotopic xenograft models of pediatric brain tumors
ITCC-P4: Molecular characterization and multi-omics analysis of pediatric patient tumor and Patient-Derived Xenograft (PDX) models for preclinical model selection
PFKFB3-Inhibition während einer Radiochemotherapie des Rektumkarzinoms – Überprüfung in einem patient-derived xenograft In-vivo-Modell
Colorectal cancer patient-derived xenograft (PDX) models as platform for drug screening, molecular and response analysis
Characterization of dormant and drug resistant stem cells using xenograft mouse models of patient-derived acute leukemia cells
Improving organotypic non-melanoma skin cancer models for advanced preclinical drug evaluation
Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy
Evaluation of photon, proton, helium, and carbon ion irradiation in prototypic NSCLC and HNSCC preclinical xenograft models
Hyperacute xenograft rejection
Impact of the injection site on growth characteristics, phenotype and sensitivity towards cytarabine of twenty acute leukaemia patient-derived xenograft models
A larval zebrafish xenograft model: evaluation of leukemia-niche interactions and its potential to predict relapsing leukemia
Enhancing Precision Oncology : Preclinical Assessment of Individual Drug Treatment Susceptibility Using Patient-Derived 3D Microtumor and Immune Cell Co-cultures
Molecular and preclinical evaluation of patient-derived orthotopic xenograft models of pediatric brain tumors
ITCC-P4: Molecular characterization and multi-omics analysis of pediatric patient tumor and Patient-Derived Xenograft (PDX) models for preclinical model selection
PFKFB3-Inhibition während einer Radiochemotherapie des Rektumkarzinoms – Überprüfung in einem patient-derived xenograft In-vivo-Modell
Colorectal cancer patient-derived xenograft (PDX) models as platform for drug screening, molecular and response analysis
Characterization of dormant and drug resistant stem cells using xenograft mouse models of patient-derived acute leukemia cells
Improving organotypic non-melanoma skin cancer models for advanced preclinical drug evaluation
Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy
Evaluation of photon, proton, helium, and carbon ion irradiation in prototypic NSCLC and HNSCC preclinical xenograft models
Hyperacute xenograft rejection
Impact of the injection site on growth characteristics, phenotype and sensitivity towards cytarabine of twenty acute leukaemia patient-derived xenograft models
A larval zebrafish xenograft model: evaluation of leukemia-niche interactions and its potential to predict relapsing leukemia